Terms: = Liver cancer AND ATF1, TREB36, 466, ENSG00000123268, P18846 AND Prognosis
20 results:
1. Impact of body mass index on the prognosis of unresectable HCC patients receiving first-line Lenvatinib or atezolizumab plus bevacizumab.
Rimini M; Stefanini B; Tada T; Suda G; Shimose S; Kudo M; Finkelmeier F; Yoo C; Presa J; Amadeo E; Genovesi V; De Grandis MC; Iavarone M; Marra F; Foschi F; Tamburini E; Rossari F; Vitiello F; Bartalini L; Soldà C; Tovoli F; Vivaldi C; Lonardi S; Silletta M; Kumada T; Sakamoto N; Iwamoto H; Aoki T; Himmelsbach V; Montes M; Hiraoka A; Sho T; Niizeki T; Nishida N; Steup C; Hirooka M; Kariyama K; Tani J; Atsukawa M; Takaguchi K; Itobayashi E; Fukunishi S; Tsuji K; Ishikawa T; Tajiri K; Ochi H; Yasuda S; Toyoda H; Ogawa C; Nishimura T; Hatanaka T; Kakizaki S; Shimada N; Kawata K; Tada F; Ohama H; Nouso K; Morishita A; Tsutsui A; Nagano T; Itokawa N; Okubo T; Arai T; Imai M; Kosaka H; Naganuma A; Koizumi Y; Nakamura S; Kaibori M; Iijima H; Hiasa Y; Persano M; Camera S; Foti S; Aldrighetti L; Cascinu S; Casadei-Gardini A; Piscaglia F
Liver Int; 2024 May; 44(5):1108-1125. PubMed ID: 38517286
[TBL] [Abstract] [Full Text] [Related]
2. Development and validation of robust metabolism-related gene signature in the prognostic prediction of hepatocellular carcinoma.
Pan Y; Zhang D; Chen Y; Li H; Wang J; Yuan Z; Sun L; Zhou Z; Chen M; Zhang Y; Hu D
J Cell Mol Med; 2023 Apr; 27(7):1006-1020. PubMed ID: 36919714
[TBL] [Abstract] [Full Text] [Related]
3. TED: Two-stage expert-guided interpretable diagnosis framework for microvascular invasion in hepatocellular carcinoma.
Zhou Y; Sun SW; Liu QP; Xu X; Zhang Y; Zhang YD
Med Image Anal; 2022 Nov; 82():102575. PubMed ID: 36063747
[TBL] [Abstract] [Full Text] [Related]
4. Activation of innate-adaptive immune machinery by poly(I:C) exposes a therapeutic vulnerability to prevent relapse in stroma-rich colon cancer.
Corry SM; McCorry AM; Lannagan TR; Leonard NA; Fisher NC; Byrne RM; Tsantoulis P; Cortes-Lavaud X; Amirkhah R; Redmond KL; McCooey AJ; Malla SB; Rogan E; Sakhnevych S; Gillespie MA; White M; Richman SD; Jackstadt RF; Campbell AD; Maguire S; ; McDade SS; Longley DB; Loughrey MB; Coleman HG; Kerr EM; Tejpar S; Maughan T; Leedham SJ; Small DM; Ryan AE; Sansom OJ; Lawler M; Dunne PD
Gut; 2022 Dec; 71(12):2502-2517. PubMed ID: 35477539
[TBL] [Abstract] [Full Text] [Related]
5. Parenchyma-sparing strategy and oncological prognosis in patients with colorectal cancer liver metastases.
Burlaka AA; Makhmudov DE; Lisnyi II; Paliichuk AV; Zvirych VV; Lukashenko AV
World J Surg Oncol; 2022 Apr; 20(1):122. PubMed ID: 35430799
[TBL] [Abstract] [Full Text] [Related]
6. High HBXIP expression is related to poor prognosis in HCC by extensive database interrogation.
Guo ZY; Jiang LP; Zhu ZT
Eur Rev Med Pharmacol Sci; 2021 Oct; 25(20):6196-6207. PubMed ID: 34730200
[TBL] [Abstract] [Full Text] [Related]
7. Preoperative gamma-glutamyltransferase to lymphocyte ratio predicts long-term outcomes in intrahepatic cholangiocarcinoma patients following hepatic resection.
Wang JJ; Li H; Li JX; Xu L; Wu H; Zeng Y
World J Gastroenterol; 2020 Apr; 26(13):1501-1512. PubMed ID: 32308350
[TBL] [Abstract] [Full Text] [Related]
8. Favourable outcome of pathologic downstaging by locoregional treatment for hepatocellular carcinoma in liver transplantation.
Kim DG; Lee JG; Joo DJ; Kim SI; Kim MS
Sci Rep; 2019 Jul; 9(1):10386. PubMed ID: 31316165
[TBL] [Abstract] [Full Text] [Related]
9. The preoperative alkaline phosphatase-to-platelet ratio index is an independent prognostic factor for hepatocellular carcinoma after hepatic resection.
Yu YQ; Li J; Liao Y; Chen Q; Liao WJ; Huang J
Medicine (Baltimore); 2016 Dec; 95(51):e5734. PubMed ID: 28002346
[TBL] [Abstract] [Full Text] [Related]
10. Activity of c-Met/ALK Inhibitor Crizotinib and Multi-Kinase VEGF Inhibitor Pazopanib in Metastatic Gastrointestinal Neuroectodermal Tumor Harboring EWSR1-CREB1 Fusion.
Subbiah V; Holmes O; Gowen K; Spritz D; Amini B; Wang WL; Schrock AB; Meric-Bernstam F; Zinner R; Piha-Paul S; Zarzour M; Elvin JA; Erlich RL; Stockman DL; Vergilio JA; Suh JH; Stephens PJ; Miller V; Ross JS; Ali SM
Oncology; 2016; 91(6):348-353. PubMed ID: 27764830
[TBL] [Abstract] [Full Text] [Related]
11. Activating KRAS mutation is prognostic only among patients who receive preoperative chemotherapy before resection of colorectal liver metastases.
Margonis GA; Kim Y; Sasaki K; Samaha M; Buettner S; Amini N; Pawlik TM
J Surg Oncol; 2016 Sep; 114(3):361-7. PubMed ID: 27264476
[TBL] [Abstract] [Full Text] [Related]
12. Significance of R1 Resection for Advanced Colorectal liver Metastases in the Era of Modern Effective Chemotherapy.
Laurent C; Adam JP; Denost Q; Smith D; Saric J; Chiche L
World J Surg; 2016 May; 40(5):1191-9. PubMed ID: 26757718
[TBL] [Abstract] [Full Text] [Related]
13. [Prognostic analysis of different treatments for synchronous colorectal liver metastasis].
Tian Y; Xu X; Gao H; Wang L; Gao Z; Zhang W
Zhonghua Wei Chang Wai Ke Za Zhi; 2015 Nov; 18(11):1115-8. PubMed ID: 26616805
[TBL] [Abstract] [Full Text] [Related]
14. An unusual association of malignant gastrointestinal neuroectodermal tumor (clear cell sarcoma-like) and Ewing sarcoma.
Insabato L; Guadagno E; Natella V; Somma A; Bihl M; Pizzolorusso A; Mainenti PP; Apice G; Tornillo L
Pathol Res Pract; 2015 Sep; 211(9):688-92. PubMed ID: 26163185
[TBL] [Abstract] [Full Text] [Related]
15. Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis.
Yamamoto Y; Ikoma H; Morimura R; Shoda K; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
World J Gastroenterol; 2015 Jan; 21(1):246-53. PubMed ID: 25574098
[TBL] [Abstract] [Full Text] [Related]
16. Hepatic resection for metastatic melanoma in The Netherlands: survival and prognostic factors.
de Ridder J; van Walsum M; Verhoef C; Nagtegaal I; de Wilt J;
Melanoma Res; 2013 Feb; 23(1):27-32. PubMed ID: 23164992
[TBL] [Abstract] [Full Text] [Related]
17. Single determination of C-reactive protein at the time of diagnosis predicts long-term outcome of patients with hepatocellular carcinoma.
Sieghart W; Pinter M; Hucke F; Graziadei I; Schöniger-Hekele M; Müller C; Vogel W; Trauner M; Peck-Radosavljevic M
Hepatology; 2013 Jun; 57(6):2224-34. PubMed ID: 22961713
[TBL] [Abstract] [Full Text] [Related]
18. No impact of perioperative blood transfusion on recurrence of hepatocellular carcinoma after hepatectomy.
Kuroda S; Tashiro H; Kobayashi T; Oshita A; Amano H; Ohdan H
World J Surg; 2012 Mar; 36(3):651-8. PubMed ID: 22270991
[TBL] [Abstract] [Full Text] [Related]
19. Clear cell sarcoma of soft tissue metastatic to the ovaries: a heretofore unreported occurrence.
Nugent SL; Dim DC; Bridge JA; Ioffe OB
Int J Gynecol Pathol; 2009 May; 28(3):234-8. PubMed ID: 19620941
[TBL] [Abstract] [Full Text] [Related]
20. TGF-beta upregulates tumor-associated carbonic anhydrase IX gene expression in Hep3B cells.
Yildirim H; Köçkar F
Cell Biol Int; 2009 Sep; 33(9):1002-7. PubMed ID: 19540352
[TBL] [Abstract] [Full Text] [Related]
